Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Urokinase for Diabetic Foot Syndrome
NCT00537498Phase 2Completed
- Sponsor
- medac GmbH
- Start
- Feb 2002
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of urokinase in diabetic foot syndrome and critical limb ischemia (CLI), sponsored by medac GmbH. Primary endpoint: Number of patients being alive, having no major amputation and healed ulceration at 12 months. Started Feb 2002; status: completed.
02
Drugs
urokinase
03
Conditions
diabetic foot syndromecritical limb ischemia (CLI)
Beyond the preview
Go deeper on NCT00537498.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00537498.